BUILT BY LIFE-SCIENCE RESEARCHERS
A private pre-submission review built for life-science authors: surface the objections, journal-fit gaps, and revision priorities that cost teams time after submission.
FROM DRAFT TO SUBMISSION
A BRIEF VIDEO TOUR
A calm tour of the real Referee workflow using a fictional manuscript.
WHAT YOU GAIN
Get ranked revision priorities alongside a credible journal path for the draft you have now.
Referee compares your manuscript across a catalog of 150 life-science journals, then anchors the review to each venue’s expectations for novelty, mechanism, rigor, scope, and audience. You see a reach, best-fit, and fallback path—not just a prestige list.
Identify statistical and methodological weaknesses before reviewers do.
It translates methods, figures, and reporting choices into reviewer-facing risk: replicate definitions, correction choices, effect sizes, pseudoreplication traps, overclaiming, and missing limitations.
Upload reviewer comments privately and assess whether the revised manuscript has adequately addressed each concern.
Referee tracks major and minor reviewer concerns against your revised manuscript, identifies what is adequately addressed, and flags what still needs work before you resubmit.
EXPLORE THE OUTPUT
Choose a card to preview the part of Referee that matters most to you. The gallery advances automatically, but you remain in control.
SIMULATED EDITORIAL RISK ESTIMATE
Critical gap: replicate structure and effect-size reporting may trigger reviewer concern.
Choose a journal sequence instead of guessing one venue at a time.
Our data prove that TIA-1 condensation drives stress-granule nucleation. Our data indicate that TIA-1 condensation is associated with stress-granule nucleation.
Thus, modulating TIA-1 phase behavior represents a promising strategy. Whether this is causal remains unresolved.
REVISION MOMENTUM
75%+24% since first review51% 63% 67% 67% 75%LIFE SCIENCE, NOT GENERIC AI
Referee is designed around the decisions life-science teams actually make: whether the evidence supports the claim, what a target venue will expect, and which revision is worth doing before the manuscript enters a slow and expensive review cycle.
DESIGN PRINCIPLES
The most useful review identifies the two or three objections most likely to change the outcome—not every possible weakness.
It is more useful to surface a statistical or mechanistic gap before submission than after peer review begins.
Referee does not promise publication outcomes. It gives authors a clearer map of risk, leverage, and next steps.
Questions about how Referee works or its limits? .
SIMPLE PRICING
When you need more reviews, editing, resubmission support, or lab collaboration, upgrade from the same workspace.
BEFORE THE DECISION LETTER
A simulation for manuscript preparation—not an editorial decision or a publication forecast.
FROM DRAFT TO SUBMISSION
WHO IT IS FOR
Prepare a submission with a clearer view of desk-rejection risk, likely reviewer objections, and whether the target journal is worth the attempt.
Avoid preventable reviewer criticism by seeing the fixes that matter first, especially around claims, figures, methods, and statistical reporting.
Decide between reach, best-fit, and cascade journals with a structured view of scope, novelty, audience, and revision burden.
BEFORE YOU SUBMIT
Sample report signal"Likely reviewer concern: statistical analysis plan is under-specified for subgroup comparisons."
WHY REFEREE IS DIFFERENT
Most AI manuscript tools help polish prose, summarize literature, or suggest generic improvements. Referee Bio is built around the decision environment: journal fit, reviewer psychology, statistical reporting, desk triage, and the specific objections that can derail a paper after months of waiting.
Feedback is interpreted against venue expectations rather than a universal checklist.
Multiple reviewer archetypes expose conflicting pressures that a single generic AI response misses.
The report checks methods, legends, and reporting signals that reviewers often use to infer fragility.
Instead of giving a long undifferentiated list, Referee identifies what changes the outcome first.
Reach, best-fit, fallback, and related journals are framed as a sequence, not a vanity list.
Turn critique into a PDF, DOCX, or TXT package for lab meetings, coauthors, and revision planning.
HOW IT WORKS
Paste text or upload a PDF, DOCX, or TXT. Select your target journal and research field. That's it — no formatting required.
Three simulated reviewer perspectives score your manuscript against the selected journal's context and write differentiated reports. You also get a statistical methods audit, section-by-section risk flags, and directional desk-triage signals.
Use the ranked fix list to prioritize. The cover letter draft and submission cascade tell you where to send it. If you get reviews back, use the Resubmission tool for a point-by-point response framework and revision assessment.
SEE IT IN ACTION
This is a fabricated walkthrough on an invented manuscript, shown to illustrate the output. Every score, signal, and comment below is generated the moment you upload — calibrated to the journal you select.
Sample only. The manuscript, journals, scores, and reviewer language shown here are fictional and for illustration. Journal names are used descriptively for submission-planning context; Referee Bio is independent and not affiliated with, endorsed by, or operated by any journal, publisher, editor, or society.
Referee turns a manuscript into a practical risk readout: likely revision burden, best-fit journal, and the outcome signals that help you decide whether to revise, redirect, or proceed.
This is a simulation for pre-submission manuscript preparation. It is not an official editorial decision, does not impersonate a journal or editor, and should not be treated as a publication forecast.
Scores separate novelty, mechanism, statistics, figures, and scope so the team can focus on the parts reviewers are most likely to punish.
The audit translates methods and figure legends into reviewer-facing risk: replicate definitions, correction choices, effect sizes, and pseudoreplication traps.
Paper type: Cell-biology imaging study with live-cell microscopy, FRAP recovery kinetics, and automated quantification of stress-granule number per cell.
Specify whether granule counts and FRAP measurements are biological or technical replicates, adopt a mixed-effects model that nests cells within independent experiments, and report 95% CIs on FRAP half-times alongside point estimates.
The cascade frames submission as a route: reach, best-fit, fallback, and what to do next if the first decision does not go your way.
Journal selection is based on primary topic, rigor, novelty, and audience — not tools or methods used. Consider Best Fit first; if rejected, move to the next tier rather than a lateral same-prestige journal with different scope.
Reach
High-impact cell biology with strong demand for mechanism and physiological relevance.
Best Fit
Best Fit reflects both strong topical alignment and the optimal selectivity tier for this manuscript's current form — not simply the highest fit score. A higher-fit reach journal may have a lower score here because its selectivity bar exceeds the manuscript's current strength.
Rigorous cell biology with emphasis on quantitative imaging, mechanism, and data quality.
Fallback
Transparent, constructive review with appetite for methodologically careful cell-biology studies.
For a higher-tier target, Referee identifies the few changes most likely to move the editorial needle instead of burying you in generic advice.
To reach Nature Cell Biology, the manuscript needs a causal mechanistic link between TIA-1 condensation and a functional cellular outcome, plus validation in a second physiological context.
These are the 3 specific changes most likely to close the gap between your submission journal and the reach journal. Ranked by likely impact on desk-triage risk.
Move beyond correlation between TIA-1 phase separation and granule number toward a causal test — for example, a separation-of-function mutant that abolishes condensation without disrupting RNA binding. The abstract should open with a mechanistic principle, not a phenotype.
Why Nature Cell Biology requires this: Nature Cell Biology weights conceptual and mechanistic advance more heavily than Journal of Cell Biology — closing this gap is the single highest-leverage change for the next selectivity tier.
Extend beyond the U2OS cell model to at least one primary or in vivo context where oxidative stress is physiologically relevant — for instance, primary neurons or a tissue oxidative-stress paradigm.
Why Nature Cell Biology requires this: Nature Cell Biology expects multi-system evidence for a central mechanistic claim rather than a single immortalized cell line.
Replace pooled-granule FRAP with per-cell nested statistics and report effect sizes with confidence intervals; add a dose-response across oxidative load rather than a single concentration.
Why Nature Cell Biology requires this: Reviewers at this tier read quantitative rigor as a proxy for whether the central mechanistic claim will hold up.
The final layer converts reviewer risk into concrete language changes, margin comments, and exportable edits your coauthors can act on.
Oxidative stress triggers the rapid assembly of cytoplasmic stress granules, membraneless organelles that sequester translationally stalled mRNAs alongside a network of RNA-binding proteins.1–4 TIA-1, a prion-like-domain protein, has been repeatedly identified as a core scaffold of these granules across human cell lines and primary cultures.5,6
Our data prove that TIA-1 condensation drives stress-granule nucleation Our data indicate that TIA-1 condensation is associated with stress-granule nucleation, with granule number scaling with the fraction of TIA-1 partitioned into the condensed phase.7 While it remains unclear whether condensation is a cause or a consequence of translational arrest, granule burden offers a tractable readout Whether condensation is a cause or a consequence of translational arrest remains unresolved. Regardless, granule burden offers a tractable, indirect readout of the cellular response to oxidative load. Thus, modulating TIA-1 phase behavior represents a promising strategy for tuning the stress response.F04 However, current approaches to perturbing condensation in living cells remain limited, and the field still lacks a separation-of-function tool that decouples assembly from RNA binding.8,9
PRIVATE
Use Referee before circulating a draft, before choosing a journal, or before a high-stakes resubmission. The goal is to expose the objections while they are still inexpensive to fix.
SPECIFIC
The same paper can look ambitious at one venue and underpowered at another. Referee frames critique against the target journal's likely tolerance for novelty, mechanism, statistics, and scope.
The product uses a journal catalog with venue-specific priors, reviewer weighting, and submission-context expectations.
Referee samples a weighted archetype pool, from constructive mentors to statistical enforcers and high-bar gatekeepers.
Reviewer mood, panel composition, and a calibrated Reviewer 2 effect model the kind of variability authors often experience in peer review.
WHAT THE MODEL CONSIDERS
Referee Bio combines AI manuscript interpretation with structured criteria such as novelty, conceptual depth, mechanism, technical strength, statistical confidence, figure strength, and scope fit. The scores are interpreted against the selected journal's culture rather than treated as universal.
The output is framed as simulated editorial risk: desk-triage vulnerability, post-review revision risk, and likely revision burden. It also ranks what to fix first so authors can improve the manuscript before submission. These are directional strategy signals, not actual journal outcome probabilities.
EXAMPLE PRIMARY REPORT
See the kind of primary manuscript report Referee generates: score criteria, reviewer-style objections, journal fit, ranked fixes, and submission strategy in one scrollable example.
REVISION MOMENTUM
Run the draft, revise the high-yield weaknesses, then watch your manuscript score improve as each version gets closer to submission-ready.
PRICING
The free paper is a trial, not a plan. Paid tiers include monthly review limits, editing access, resubmission tools, history, exports, and seats.
BEFORE THE DECISION LETTER
